Comparison of the effects of digoxin or enalapril in the treatment of heart failure due to mitral insufficiency;Comparación de digoxina y enalapril en insuficiencia cardíaca secundaria a insuficiencia mitral

Revista Medica de Chile

Volumn 126, Issue 3, 1998, Pages 251-257

  Lanas Z, Fernando ^b   Garcés F, Eduardo ^a   Eggers R, Germán ^a   Montecinos L, Angélica ^a   Díaz M, Marta ^a   Gamboa C, Claudio ^a   Stockins F, Benjamin ^a  

^a Enfermera Universitaria ^*

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

Congestive; Digoxin; Enalapril; Heart failure; Mitral valve insufficiency; Therapy

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE TOLERANCE; FEMALE; HEART VENTRICLE; HUMAN; MALE; MITRAL VALVE REGURGITATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIGOXIN; DOUBLE-BLIND METHOD; ENALAPRIL; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY;

EID: 0032013589     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. COHN JN. Drug therapy: The management of chronic heart failure. N Engl J Med 1990; 335: 490-8.
2. VAN VELDHUISEN DJ, DE GRAEFF PA, RENME WJ; LIE KI. Value of digoxin in heart failure and sinus rhythm: new features of an old drug. J Am Coll Cardiol 1966; 28: 813-9.
3. CHAITEHJEE K, PARMLEY WW, SWAN HJC, ET AL. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 1973; 48: 648-89.
4. STEVENSON LW, DRUNKEN RC, BETEL D, ET AL. Afterload reduction with vasodilators and diuretics-decreases mitral regurgitation during upright exercise in advance heart failure. J Am Coll Cardiol 1990; 15: 174-80.
5. SCHÖN HR, SCHRÖTER G, BLÖMER H, SCHÖMIG A. Beneficial effects of a single dose of quinalapril on left ventricular performance in chronic mitral regurgitation. Am J Cardiol 1994; 73: 785-91.
6. SCHÖN HR, SCHRÖTER G, BARTHEL P, SCHÖMIG A. Quinalapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994; 3: 303-12.
7. WISENBAUGH T, SIMOVICH V, DULLABH A, SARELI P. Six month pilot study of captopril for mildly symptomatic severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994; 3: 197-204.
8. PRASAD K, O'NEIL CL, BHARADWAJ B. Effects of chronic digoxin treatment on cardiac function, electrolytes, and sarcolemmal ATPase in the canine failing heart due to chronic mitral regurgitation. Am Heart J 1984; 108: 1487-94.
9. BEAUNE J. Comparison of enalapril versus digoxin for congestive heart failure. Am J Cardiol 1989; 63: 22D-25D.
10. THE CAPTOPRIL-DIGOXIN MULTICENTER RESEARCH GROUP. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heat failure. JAMA 1988; 259: 539-44.
11. KROMER EP, ELSNER D, RIEGGER GAJ. Digoxin, converting-enzyme inhibition (quinalapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm. J Cardiovasc Pharmacol 1990; 6: 9-14.
12. DAVIES RF, BEANLANDS D, MADEAU C ET AL, FOR THE CANADIAN ENALAPRIL VERSUS DIGOXIN GROUP. J Am Coll Cardiol 1991; 18: 1602-9.
13. THE CRITERIA COMMITTEE OF THE NEW YORK HEART ASSOCIATION. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 6th ed. Boston: Little Brown 1904; 1: 23.
14. SAHN D, DE MARIA A, KISSLO J. Recommendations regarding quantitation in M-Mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978: 1072.
15. SPAIN MG, SMITH MD, GRAYBURN PA, HARLAMERT EA, DEMARIA AN. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989; 13: 585-90.
16. BRUCE RA. Exercise testing of patients with coronary heart disease. Ann Clin Res 1971; 3: 323.
17. HILLS M, ARMTAGE P. The two-period cross-over clinical trial. Brit J Clin pharmacol 1979; 8: 7-20.
18. FLEIS JL. Statistical methods for rates and proportions. New York: Willey, 1993.
19. URETSKY BF, YOUNG JB, SHAHIDI FE ET Al., ON BEHALF OF THE PROVED INVESTIGATIVER GROUP. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. LT Am Coll Cardiol 1993; 22: 955-62.
20. PACKER M, GHEORGHIADE M, YOUNG JB ET AL., FOR THE RADIANCE STUDY. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzime inhibitors. N Engl J Med 1993; 329: 1-7.
21. MOROCCO C, CUOCOLO A, ROMANO M, ET AL. Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. Am J Carding 1996; 77: 480-5.
22. LANAS F, STANDEN D, STEINMANN W, ET AL. La digoxina es efectiva en el tratamiento de pacientes con insuficiencia cardíaca en ritmo sinusal. Rev Méd Chil 1994; 122: 1147-52.
23. LANAS F, SALVATICI R, CASTILLO G, ET AL. Comparación de digoxina y atenolol en fibrilación auricular crónica. Rev Méd Chile 1995; 123: 1252-6.
24. GHEORGHIADE M, HALL VB, JACOBSEN G, ET AL. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation 1995; 92: 1801-7.
25. FERGUSON DW, BERG WJ, SANDERS JS, ET AL. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Circulation 1989; 80: 65-77.
26. THE DIGITALIS INVESTIGATION GROUP. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33.
27. NARANG R, SWEDBERG K, CLELAND JFG. What is the ideal study design for evaluation of treatment for heart failure? Eur Heart J 1966; 17: 120-34.
28. KONSTAM MA, ROUSSEAU MF, KRONENBEG MW. Effects of the angiotensin converting enzime inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992; 86: 431-8.
29. KONSTAM MA, ROUSSEAU MF, KRONENBEG MW. Effects of the angiotensin converting enzime inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. Circulation 1993; 88: 227-228.
30. SENEMRATNE B, MOORE GA, WEST PD. Effects of captopril on functional mitral regurgitation in dilated heart failure: a randomized double blind placebo controlled trial. Br Heart J 1994; 72: 63-8.
31. VORAN C, YELLIN EL, DECKER RM ET AL. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 1979; 43: 773-7.